欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	DK/H/0899/001
药品名称	Lafunomyl
活性成分	alfuzosin hydrochloride 5.0 mg
剂型	Prolonged-release tablet
上市许可持有人	Viatris Limited Damastown Industrial Park Mulhuddart Dublin 15 Ireland
参考成员国 - 产品名称	Denmark (DK) Lafunomyl
互认成员国 - 产品名称	United Kingdom (Northern Ireland) (XI) Portugal (PT)
许可日期	2006/03/23
最近更新日期	2022/09/19
药物ATC编码	G04CA01 alfuzosin
申请类型	TypeLevel1：Abridged TypeLevel2：Initial Application TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC TypeLevel4：Chemical Substance TypeLevel5：Prescription Only
附件文件下载	Final PL \| common-combined-dk0899-10mg-clean-v047gDate of last change:2021/04/21 Final PL \| common-combined-dk0899-5mg-clean-v047gDate of last change:2021/04/21 Final Product Information \| common-combined-dk0899-10mg-clean-v044rtq2-v046Date of last change:2020/12/22 Final Product Information \| common-combined-dk0899-5mg-clean-v044rtq2-v046Date of last change:2020/12/22 Final SPC \| common-spc-10mgcleanversionDate of last change:2012/07/27 Final SPC \| common-spc-5mgcleanversionDate of last change:2012/07/27 Final Labelling \| Labelling 10 mg track version 11-11-2010Date of last change:2011/02/02 Final Labelling \| Labelling 5 mg 11-11-2010Date of last change:2011/02/02
市场状态	Positive